Chemed (CHE) to Release Earnings on Tuesday

Chemed (NYSE:CHE) is anticipated to issue its quarterly earnings data after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of $6.78 per share and revenue of $636.10 million for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Chemed Price Performance

Shares of CHE stock opened at $553.10 on Tuesday. The company has a market cap of $8.32 billion, a price-to-earnings ratio of 27.95, a PEG ratio of 2.16 and a beta of 0.48. The firm has a fifty day moving average price of $542.45 and a 200-day moving average price of $564.40. Chemed has a 1 year low of $512.12 and a 1 year high of $654.62.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. Chemed’s payout ratio is currently 10.11%.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the sale, the chief executive officer now directly owns 101,735 shares in the company, valued at approximately $58,270,755.95. This represents a 1.93 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the company’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the sale, the executive vice president now owns 18,287 shares in the company, valued at approximately $10,526,362.94. This trade represents a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CHE. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th. Royal Bank of Canada dropped their price objective on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.